Yesterday and today the Children's Oncology Group Biology Committee met to discuss important new ways to help risk stratify patients with childhood brain tumors, as well as exciting potential new therapeutic approaches. We presented some of our work on targeting the ubiquitin-proteasome system in medulloblastoma. The highlight of the meeting, though, was the collaborative nature and the great scientific exchanges.
Friday, August 28, 2009
COG CNS Biology Committee Meeting in Bethesda
Yesterday and today the Children's Oncology Group Biology Committee met to discuss important new ways to help risk stratify patients with childhood brain tumors, as well as exciting potential new therapeutic approaches. We presented some of our work on targeting the ubiquitin-proteasome system in medulloblastoma. The highlight of the meeting, though, was the collaborative nature and the great scientific exchanges.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment